{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:53:52Z","timestamp":1794682432447,"version":"4.9.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Intravenous immunoglobulin (IVIG) has been widely used to treat the hemolytic disease of the newborn (HDN). Although it has been shown that IVIG treatment reduces the duration of phototherapy and hospitalization, the use of IVIG in hemolytic disease due to ABO incompatibility has been controversial in recent years. This study aimed to investigate the role of IVIG in the prevention of exchange transfusion in infants with ABO HDN who presented with bilirubin levels at or above the level of exchange transfusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>This study evaluated the data of infants with ABO HDN in the Turkish Neonatal Jaundice Online Registry. The infants with ABO HDN who met the total serum bilirubin level inclusion criteria (within 2\u20133 mg\/dL of exchange transfusion or even above exchange transfusion level) were included in the study according to the guidelines from the American Academy of Pediatrics and the Turkish Neonatal Society. All patients were managed according to the unit protocols recommended by these guidelines and received light-emitting diode (LED) phototherapy. Infants who only received LED phototherapy, and who received one dose of IVIG with LED phototherapy were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the study period, 531 term infants were included in the study according to inclusion criteria. There were 408 cases in the phototherapy-only group, and 123 cases in the IVIG group. The demographic findings and the mean bilirubin and reticulocyte levels at admission were similar between the groups (<jats:italic>p<\/jats:italic> &amp;gt; 0.05), whereas the mean hemoglobin level was slightly lower in the IVIG group (<jats:italic>p<\/jats:italic> = 0.037). The mean age at admission was earlier, the need for exchange transfusion was higher, and the duration of phototherapy was longer in the IVIG group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001, <jats:italic>p<\/jats:italic> = 0.001, and <jats:italic>p<\/jats:italic> &amp;lt; 0.001, respectively). The rate of re-hospitalization and acute bilirubin encephalopathy (ABE) was higher in the IVIG group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001 and <jats:italic>p<\/jats:italic> = 0.01, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this study, we determined that one dose of IVIG did not prevent an exchange transfusion nor decrease the duration of phototherapy in infants, who had bilirubin levels near or at exchange transfusion level, with hemolytic disease due to ABO incompatibility.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.864609","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T11:51:30Z","timestamp":1681818690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion"],"prefix":"10.3389","volume":"10","author":[{"given":"Emel","family":"Okulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Erdeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Olukman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebnem","family":"Calkavur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Buyukkale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merih","family":"Cetinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Ulubas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Hanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahattin","family":"Ertugrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazli Dilay","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihat","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejat","family":"Narli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duran","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Terek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Altun","family":"Koroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Seren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Ozyazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Narter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Ozyazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Zenciroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin Selim","family":"Asker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynel","family":"Gokmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Salihli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bulbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Zubarioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begum","family":"Atasay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Turkish Neonatal Society IVIG Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"F83","DOI":"10.1136\/adc.2005.076794","article-title":"Haemolytic disease of the newborn","volume":"92","author":"Murray","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.clp.2021.05.006","article-title":"Hyperbilirubinemia in the term infant: re-evaluating what we think we know","volume":"48","author":"Hammerman","year":"2021","journal-title":"Clin Perinatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/apa.14142","article-title":"Uniform national guidelines do not prevent wide variations in the clinical application of phototherapy for neonatal jaundice","volume":"107","author":"Mreihil","year":"2018","journal-title":"Acta Paediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"CD003313","DOI":"10.1002\/14651858.CD003313.pub2","article-title":"Immunoglobulin for alloimmune hemolytic disease in neonates","volume":"3","author":"Zwiers","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1111\/trf.13721","article-title":"Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study","volume":"56","author":"Lieberman","year":"2016","journal-title":"Transfusion."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1542\/neo.11-7-e370","article-title":"Intravenous immune globulin: clinical applications in the newborn","volume":"11","author":"Navarro","year":"2010","journal-title":"NeoReviews"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0193108","DOI":"10.1371\/journal.pone.0193108","article-title":"The Turkish neonatal jaundice online registry: a national root cause analysis","volume":"13","author":"Erdeve","year":"2018","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.5152\/TurkPediatriArs.2018.01816","article-title":"Turkish neonatal society guideline to the approach, follow-up, and treatment of neonatal jaundice","volume":"53","author":"\u00c7oban","year":"2018","journal-title":"Turk Pediatri Ars."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/jp.2008.211","article-title":"Clinical report from the pilot USA kernicterus registry (1992 to 2004)","volume":"29","author":"Johnson","year":"2009","journal-title":"J Perinatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1651-2227.1999.tb01085.x","article-title":"High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice","volume":"88","author":"Alpay","year":"1999","journal-title":"Acta Paediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.siny.2015.10.006","article-title":"Hemolytic disease of the fetus and newborn in the molecular era","volume":"21","author":"Fasano","year":"2016","journal-title":"Semin Fetal Neonatal Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-008-3002-0","article-title":"Advances in the understanding of the mechanism of action of IVIg","volume":"3","author":"Hartung","year":"2008","journal-title":"J Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1651-2227.1991.tb11828.x","article-title":"High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility","volume":"80","author":"Sato","year":"1991","journal-title":"Acta Paediatr Scand."},{"key":"B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1423-0410.1995.tb01676.x","article-title":"Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin","volume":"69","author":"Ergaz","year":"1995","journal-title":"Vox Sang."},{"key":"B16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/BF02724308","article-title":"Intravenous immunoglobulins in rhesus hemolytic disease","volume":"70","author":"Mukhopadhyay","year":"2003","journal-title":"Indian J Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/jmf.16.3.163.166","article-title":"Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn","volume":"16","author":"Miqdad","year":"2004","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1542\/peds.2006-2910","article-title":"A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality","volume":"120","author":"Steiner","year":"2007","journal-title":"Pediatrics."},{"key":"B19","doi-asserted-by":"publisher","first-page":"F325","DOI":"10.1136\/archdischild-2013-304878","article-title":"Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis","volume":"99","author":"Louis","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41372-021-00963-5","article-title":"Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study","volume":"41","author":"Pan","year":"2021","journal-title":"J Perinatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12185-011-0853-4","article-title":"Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates","volume":"93","author":"Demirel","year":"2011","journal-title":"Int J Hematol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000244350","article-title":"Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy","volume":"70","author":"Hammerman","year":"1996","journal-title":"Biol Neonate."},{"key":"B23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1056\/NEJMct0708376","article-title":"Phototherapy for neonatal jaundice","volume":"358","author":"Maisels","year":"2008","journal-title":"N Engl J Med."},{"key":"B24","first-page":"491","article-title":"Kernicterus in full-term infants-United States, 1994\u20131998","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0095-5108(18)30116-7","article-title":"Jaundice in full-term and near-term babies who leave the hospital within 36 hours. The pediatrician's nemesis","volume":"25","author":"Maisels","year":"1998","journal-title":"Clin Perinatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/jp.2012.71","article-title":"An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation","volume":"32","author":"Maisels","year":"2012","journal-title":"J Perinatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12887-015-0358-z","article-title":"Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings","volume":"15","author":"Olusanya","year":"2015","journal-title":"BMC Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000445708","article-title":"Neonatal jaundice in low- and middle-income countries: lessons and future directions from the 2015 don ostrow trieste yellow retreat","volume":"110","author":"Greco","year":"2016","journal-title":"Neonatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000330055","article-title":"Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium?","volume":"100","author":"Kaplan","year":"2011","journal-title":"Neonatology."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.864609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T11:51:33Z","timestamp":1681818693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.864609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":29,"alternative-id":["10.3389\/fped.2022.864609"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.864609","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"864609"}}